Differential expression and quantitation of 5-alpha reductase (5αR) in prostate cancer

被引：0
|
作者：
Chikkamuniyappa, S [1 ]
McMasters, R [1 ]
Ghosh, P [1 ]
Thompson, I [1 ]
Leach, R [1 ]
Troyer, D [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
612
引用
收藏
页码：133A / 133A
页数：1
相关论文
共 50 条
  • [21] PROSTATE BIOPSY AFTER TREATMENT WITH 5-ALPHA REDUCTASE INHIBITORS MARKEDLY ENHANCES PROSTATE CANCER DETECTION
    Kaplan, Steven
    Lee, Richard
    Chung, Doreen E.
    Scherr, Douglas
    Te, Alexis
    Vaughan, E. Darracott
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E773 - E773
  • [22] Gene expression profiling of prostate tissue based on variable expression of 5-alpha reductase 2.
    Salari, Keyan
    Bechis, Seth
    Ge, Rongbin
    Hong, Jian
    Otsetov, Aleksander
    Wang, Zongwei
    Wu, Chin-Lee
    Tabatabaei, Shahin
    Olumi, Aria F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [23] Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
    Ge Rongbin
    Wang, Zongwei
    Wu, Chin-Lee
    Tabatabaei, Shahin
    Olumi, Aria
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [24] Variable expression of 5-alpha reductase 2 in the aging adult prostate is regulated by DNA methylation
    Ge Rongbin
    Wang, Zongwei
    Bechis, Seth
    Otsetov, Alexander
    Hua, Shengyu
    Wu, Shulin
    Wu, Chin-Lee
    Tabatabaei, Shahin
    Olumi, Aria
    [J]. CANCER RESEARCH, 2015, 75
  • [25] DYNAMIC EXPRESSION OF 5-ALPHA REDUCTASE 2 IN AGING PROSTATE IS REGULATED BY DNA METHYLTRANSFERASE 1
    Ge, Rongbin
    Wang, Zongwei
    Wu, Chin-Lee
    Tabatabaei, Shahin
    Olumi, Aria
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E661 - E661
  • [26] Effects of Curcumin Combined With the 5-alpha Reductase Inhibitor Dutasteride on LNCaP Prostate Cancer Cells
    Nakayama, Akinori
    Ide, Hisamitsu
    Lu, Yan
    Takei, Ayano
    Fukuda, Kazunori
    Osaka, Akiyoshi
    Arai, Gaku
    Horie, Shigeo
    Okada, Hiroshi
    Saito, Kazutaka
    [J]. IN VIVO, 2021, 35 (03): : 1443 - 1450
  • [27] Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
    Stephanie R. Earnshaw
    Cheryl L. McDade
    Libby K. Black
    Christopher F. Bell
    Michael W. Kattan
    [J]. PharmacoEconomics, 2010, 28 : 489 - 505
  • [28] INCIDENCE OF FALSE NEGATIVE PROSTATE CANCER SCREENING IN PATIENT TAKING 5-ALPHA REDUCTASE INHIBITORS
    Fram, Ethan
    Maria, Pedro
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1033 - E1034
  • [29] Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Black, Libby K.
    Bell, Christopher F.
    Kattan, Michael W.
    [J]. PHARMACOECONOMICS, 2010, 28 (06) : 489 - 505
  • [30] COMPARISON OF FINASTERIDE (PROSCAR(R)), A 5-ALPHA REDUCTASE INHIBITOR, AND VARIOUS COMMERCIAL PLANT-EXTRACTS IN INVITRO AND INVIVO 5-ALPHA REDUCTASE INHIBITION
    RHODES, L
    PRIMKA, RL
    BERMAN, C
    VERGULT, G
    GABRIEL, M
    MALICE, MP
    GIBELIN, B
    [J]. PROSTATE, 1993, 22 (01): : 43 - 51
12345